NOCIL (NOCIL) Q4 24/25 earnings summary

Executive summary

• Q4 FY25 revenue from operations reached INR 340 crores, up 7% sequentially, with 4% volume growth; annual revenue was INR 1,393 crores, down from INR 1,445 crores in FY24.

• Largest rubber chemicals manufacturer in India with over four decades of expertise and global recognition for technical capabilities.

• Domestic business showed flat growth due to low-priced imports, while international business achieved double-digit growth for the second consecutive year.

• Strategic focus on sustainability, innovation, and expanding market share in Asia, Europe, and the US.

• Annual audited standalone and consolidated financial results for the year ended March 31, 2025, were approved by the Board on May 15, 2025.

Financial highlights

• FY25 revenue from operations declined 4% year-over-year to INR 1,393 crores; Q4 FY25 revenue grew 7% sequentially but fell 5% year-over-year.

• Operating EBITDA for FY25 was INR 137 crores (9.9% margin), down from INR 195 crores (13.5% margin) in FY24; Q4 FY25 EBITDA was INR 34 crores (10.1% margin).

• Net profit for FY25 was INR 103 crores (consolidated: INR 102.86 crores), down from INR 133 crores (consolidated: INR 133 crores) in FY24; Q4 FY25 net profit rose 61% sequentially.

• Cash flow from operations dropped to INR 26 crores in FY25 from INR 201 crores in FY24.

• Earnings per share (consolidated, basic) for FY25 was INR 6.17, down from INR 7.98 in FY24.

Outlook and guidance

• Ongoing INR 250 crore capex at Dahej facility to expand TDQ antioxidant production remains on track.

• Management expects domestic demand to remain robust, with tire sector CAGR projected at 4%-6%.

• Export markets are expected to drive stronger growth, though international outlook is uncertain due to tariffs and global dynamics.

• Continued emphasis on R&D, green chemistry, and new product development to drive future growth.

• The Board recommended a final dividend of Rs.2 per share, pending shareholder approval at the AGM on August 7, 2025.